HAWKHILL THERAPEUTICS Ltd

New Filing
CIK: 0002140690·Biotechnology·UNITED KINGDOM·Filed: Jun 22, 2026
Total Offering

$192,569

Amount Sold

$192,569

Investors

1

First Sale

Apr 7, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
Christopher Andrew Woodland
Antoine Boulanger
Mary Canning
Francisca Peixoto
Timothy Jason Sparey

Company

HAWKHILL THERAPEUTICS Ltd

LIFE SCIENCES INNOVATION HUB

DUNDEE, SCOTLAND, X0, DD1 5JJ

5555555555

SEC Filing

0002140690-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free